---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-162609"
form_type: "8-K"
ticker: "TNGX"
cik: "0001819133"
company_name: "Tango Therapeutics, Inc."
filed_at: "2023-06-07T23:59:59+00:00"
generated_at: "2026-06-14T06:00:00.069346+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Tango Therapeutics stockholders elect two Class II directors and ratify PwC as auditor

## Summary
- Malte Peters, M.D. elected with 75,943,817 votes for, 3,532,483 withheld (5,145,731 broker non-votes).
- Mace Rothenberg, M.D. elected with 76,746,614 votes for, 2,729,682 withheld (5,145,731 broker non-votes).
- Ratification of PricewaterhouseCoopers as auditor: 84,619,141 for, 2,888 against, 2 abstain.
- Quorum of 95.93% (84,622,031 of 88,209,964 shares) present at virtual annual meeting.

## SEC filing metadata
- accession: 0001193125-23-162609
- form_type: 8-K
- ticker: TNGX
- cik: 0001819133
- company_name: Tango Therapeutics, Inc.
- filed_at: 2023-06-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819133/000119312523162609/0001193125-23-162609-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819133/000119312523162609/d512389d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-162609
- JSON: https://secwatch.observer/filing/0001193125-23-162609.json
- Plain text: https://secwatch.observer/filing/0001193125-23-162609.txt

## Key facts
- Shareholder Votes
  Tango Therapeutics, Inc. shareholders approved Election of two Class II director nominees to the Board of Directors at the 2023-06-06 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: The results of the election were as follows: CLASS II DIRECTOR NOMINEE FOR WITHHELD BROKER NON-VOTES Malte Peters, M.D. 75,943,817 3,532,483 5,145,731 Mace Rothenberg, M.D. 76,746,614 2,729,682 5,145,731
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819133/000119312523162609/0001193125-23-162609-index.htm
- Shareholder Votes
  Tango Therapeutics, Inc. shareholders approved Ratification of the selection of PricewaterhouseCoopers, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-06 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: The results of the ratification were as follows: FOR AGAINST ABSTAIN 84,619,141 2,888 2
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819133/000119312523162609/0001193125-23-162609-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.